33 results on '"Radu, Claudia M."'
Search Results
2. In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency
3. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
4. Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection.
5. Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis
6. In vitroand ex vivorescue of a nonsense mutation responsible for severe coagulation factor V deficiency
7. Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: a comparison between 3-factor and 4-factor prothrombin complex concentrates
8. Dynamics of circulating microparticles in obesity after weight loss
9. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism
10. Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
11. Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia
12. Comparison of thrombin generation in transplanted primates recipients of pig hDaf or hDaf-GalT-KO kidney: 400
13. Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings
14. Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals
15. Levels of circulating microparticles in septic shock and sepsis-related complications: a case-control study
16. Partial F8gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia
17. Albumin uptake in human podocytes: a possible role for the cubilin-amnionless (CUBAM) complex
18. Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity
19. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
20. Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?
21. Endocytosis of exogenous factor V byex-vivodifferentiated megakaryocytes from patients with severe parahaemophilia
22. Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis
23. Microparticles as biomarkers of venous thromboembolic events
24. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S
25. Activated Platelet‐Derived and Leukocyte‐Derived Circulating Microparticles and the Risk of Thrombosis in Heparin‐Induced Thrombocytopenia: A Role for PF4‐Bearing Microparticles?
26. Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia
27. Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women
28. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events
29. Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia.
30. Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity
31. Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis
32. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
33. Circulating microparticles in carriers of prothrombin G20210A mutation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.